TABLE 2.
Patient Characteristics for the Intent-to-Treat Sample and the Treatment Groups in a Study of Continuation ECT in Geriatric Depressiona
| Characteristic | Total Sample (N=120) | ECT Plus Medication (N=61) | Medication Only (N=59) | |||
|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | |
| Age (years) | 70.5 | 7.2 | 70.8 | 7.2 | 70.3 | 7.3 |
| Education (years) | 14.5 | 3.3 | 14.4 | 3.3 | 14.5 | 3.4 |
| Hamilton Depression Rating Scale (24 item) | ||||||
| Baseline, phase 1 | 30.3 | 7.4 | 29.6 | 6.8 | 31.1 | 7.9 |
| Baseline, phase 2 | 6.1 | 2.5 | 6.0 | 2.5 | 6.1 | 2.5 |
| Mini-Mental State Examination | ||||||
| Baseline, phase 1 | 27.5 | 2.2 | 27.6 | 2.2 | 27.4 | 2.3 |
| Baseline, phase 2 | 27.9 | 2.4 | 27.9 | 2.5 | 27.8 | 2.4 |
| Clinical Global Impressions severity scale | ||||||
| Baseline, phase 1 | 5.2b | 0.9 | 5.1b | 0.8 | 5.3 | 0.9 |
| Baseline, phase 2 | 1.9 | 0.9 | 1.9 | 0.9 | 1.8 | 0.8 |
| Seizure threshold (mC) (baseline, phase 1) | 29.8b | 12.8 | 29.4b | 12.7 | 30.1 | 13.0 |
| Prior antidepressants (baseline, phase 1) | 2.3c | 1.5 | 2.3d | 1.6 | 2.4e | 1.5 |
| N | % | N | % | N | % | |
| Female | 74 | 61.7 | 37 | 60.7 | 37 | 62.7 |
| White | 114 | 95 | 58 | 95.1 | 56 | 94.9 |
| Psychosis (at baseline) | 17 | 14.2 | 5 | 8.2 | 12 | 20.3 |
| Age group (years) | ||||||
| 60–69 | 57 | 47.5 | 29 | 47.5 | 28 | 47.5 |
| 70–79 | 49 | 40.8 | 24 | 39.3 | 25 | 42.4 |
| 80–89 | 14 | 11.7 | 8 | 13.1 | 6 | 10.2 |
No significant difference between groups on any variable; baseline psychosis approached significance, at p=0.06.
Missing data for one subject.
Missing data for 15 subjects.
Missing data for 10 subjects.
Missing data for five subjects.